Gastroenterology
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Global pharma market insights for gastroenterology: track drug development, regulatory approvals, and M&A for IBD, liver disease, and GI oncology.
Showing 1–4 of 4 articles
Quick answer
NovaPharmaNews Gastroenterology hub for EMA covers 4 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Heart Failure 2026: Vutrisiran Data & European Pharma News
SynbioTech Unveils Microbiome-Based Platform for Women's Healthy Aging at Vitafoods Europe 2026
EnteroBiotix Raises £19M to Launch Phase 2b Microbiome Trial for Irritable Bowel Syndrome Treatment
Implantica RefluxStop Device Shows Excellent Long-Term Safety in Landmark 602-Patient European Study
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.